2021
DOI: 10.1080/00365513.2021.1876245
|View full text |Cite
|
Sign up to set email alerts
|

Chronic inflammation involves CCL11 and IL-13 to facilitate the development of liver cirrhosis and fibrosis in chronic hepatitis B virus infection

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

1
15
0

Year Published

2021
2021
2024
2024

Publication Types

Select...
8

Relationship

0
8

Authors

Journals

citations
Cited by 17 publications
(17 citation statements)
references
References 84 publications
1
15
0
Order By: Relevance
“… 34 However, we are first to show increased CCL11 expression in Sharpin-/- exposed mice. It has been suggested that IL-13 and CCL11 are involved in chronic liver inflammation in chronic hepatitis B viral infection 53 and IL4/IL13, which with TGF-β, has been shown importance in airway fibrosis in asthma. 54 Whether IL-4/IL-13 and CCL11 were synergistically involved in inducing chronic inflammation and tissue remodeling in esophagus in our model of EoE require further investigation.…”
Section: Discussionmentioning
confidence: 99%
“… 34 However, we are first to show increased CCL11 expression in Sharpin-/- exposed mice. It has been suggested that IL-13 and CCL11 are involved in chronic liver inflammation in chronic hepatitis B viral infection 53 and IL4/IL13, which with TGF-β, has been shown importance in airway fibrosis in asthma. 54 Whether IL-4/IL-13 and CCL11 were synergistically involved in inducing chronic inflammation and tissue remodeling in esophagus in our model of EoE require further investigation.…”
Section: Discussionmentioning
confidence: 99%
“…HBV viral load has not been associated with controlled attenuation parameter (CAP) liver stiffness measurement (LSM) scores in chronic HBV patients. The implication of metabolic components in liver disease progression and NAFLD development has also been shown in CHB patients, as they had a significant positive correlation with fibrosis/cirrhosis and hepatic steatosis ( 53 ). Specific plasma markers of CHB, such as CCL11, IL-6, IL-4, IL-13 and G-CSF have been shown to have a significant influence on the CAP and LSM scores independent of metabolic components.…”
Section: Effect Of Hbv Viral Load and Specific Plasma Markers On Nafl...mentioning
confidence: 91%
“…Non-alcoholic fatty liver disease (NAFLD) is a hepatic manifestation of metabolic syndrome where symptoms can range from accumulation of fatty droplets in liver cells to development of inflammatory steatohepatitis (NASH) that may further progress to liver fibrosis, cirrhosis and liver failure or onset of hepatocellular carcinoma (HCC). 77,78 Together with HBV, NAFLD represents the two most prevalent liver diseases reported from across the world. 77,79,80 Viral hepatitis and metabolic syndrome (e.g.…”
Section: Mait Cells and Non-alcoholic Fatty Liver Disease (Nafld)mentioning
confidence: 99%
“…77,78 Together with HBV, NAFLD represents the two most prevalent liver diseases reported from across the world. 77,79,80 Viral hepatitis and metabolic syndrome (e.g. obesity, type 2 diabetes (T2D), and hypertriglyceridemia) are the common precursors for the development of NAFLD and is usually reversible.…”
Section: Mait Cells and Non-alcoholic Fatty Liver Disease (Nafld)mentioning
confidence: 99%
See 1 more Smart Citation